Abstract
Pancreatic cancer is one of the most common human cancers with very low survival rate. So far, the difficulties to make early diagnosis and find curative therapy for this malignant disease remain challenging. Considering Chinese medicine with a long history of clinical application in treating various human diseases, it has been now introduced into the anti-cancer treatment and begun to attract attentions of researchers worldwide. Here, we summarize the recent studies on the anti-tumor activity of Chinese medicine in human pancreatic cancer and the potential molecular mechanisms.
Keywords: Chinese medicine, pancreatic cancer, therapy.
Current Signal Transduction Therapy
Title:Chinese Medicine: A Novel Therapeutic Option for Pancreatic Cancer
Volume: 9 Issue: 1
Author(s): Ping Yan, Yongxing Cao and Xiaotian Sun
Affiliation:
Keywords: Chinese medicine, pancreatic cancer, therapy.
Abstract: Pancreatic cancer is one of the most common human cancers with very low survival rate. So far, the difficulties to make early diagnosis and find curative therapy for this malignant disease remain challenging. Considering Chinese medicine with a long history of clinical application in treating various human diseases, it has been now introduced into the anti-cancer treatment and begun to attract attentions of researchers worldwide. Here, we summarize the recent studies on the anti-tumor activity of Chinese medicine in human pancreatic cancer and the potential molecular mechanisms.
Export Options
About this article
Cite this article as:
Yan Ping, Cao Yongxing and Sun Xiaotian, Chinese Medicine: A Novel Therapeutic Option for Pancreatic Cancer, Current Signal Transduction Therapy 2014; 9 (1) . https://dx.doi.org/10.2174/157436240901140924103948
DOI https://dx.doi.org/10.2174/157436240901140924103948 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Deregulation of HOX B13 Expression in Urinary Bladder Cancer Progression
Current Medicinal Chemistry Molecular Mechanism of Anti-tumor Effect by Triptolide in Hematological Malignancies
Current Signal Transduction Therapy Imaging Requirements for Personalized Medicine: The Oncologists Point of View
Current Pharmaceutical Design Relaxin-Like Peptides in Neoplastic Lesions
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC)
Current Cancer Drug Targets RAGE and RAGE Ligands in Cancer
Current Molecular Medicine Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential Applications
Current Pharmaceutical Design Challenges from Clustering Analysis to Knowledge Discovery in Molecular Biomechanics
Current Bioinformatics Transcriptional Analysis of JAK/STAT Signaling in Glioblastoma Multiforme
Current Pharmacogenomics and Personalized Medicine Importance of Wnt Signaling in the Tumor Stroma Microenvironment
Current Cancer Drug Targets Design, Synthesis and In-Vitro Evaluation of Polymer-linked Prodrug of Methotrexate for the Targeted Delivery to the Colon
Letters in Drug Design & Discovery Pharmaceutical Applications of Graphene-based Nanosheets
Current Pharmaceutical Biotechnology Effects of Estrogens on Atherogenesis
Current Vascular Pharmacology Signalling Pathways Activated by Ultraviolet Radiation: Role in Ocular and Cutaneous Health
Current Pharmaceutical Design Signal Transducer and Activator of Transcription 3 Signaling Pathway: A Potential Target in Sarcoma Treatment
Current Enzyme Inhibition From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Current Neuropharmacology Silk Fibroin Based Drug Delivery Applications: Promises and Challenges
Current Drug Targets Meet Our Editor-in-Chief
Clinical Cancer Drugs Redox-active and Redox-silent Compounds: Synergistic Therapeutics in Cancer
Current Medicinal Chemistry